Advisor OS LLC Sells 230 Shares of CME Group Inc. (NASDAQ:CME)

Advisor OS LLC lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 10.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,934 shares of the financial services provider’s stock after selling 230 shares during the quarter. Advisor OS LLC’s holdings in CME Group were worth $380,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CME. Vanguard Group Inc. increased its holdings in CME Group by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after buying an additional 215,044 shares during the period. Capital International Investors boosted its stake in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares in the last quarter. Capital World Investors boosted its stake in shares of CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after purchasing an additional 1,172,575 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of CME Group by 2.9% in the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after purchasing an additional 189,842 shares in the last quarter. Finally, Parnassus Investments LLC boosted its stake in shares of CME Group by 0.4% in the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock valued at $1,193,551,000 after purchasing an additional 23,583 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Bank of America downgraded shares of CME Group from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $212.00 to $177.00 in a research report on Tuesday, September 3rd. Barclays upped their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft upped their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Finally, Piper Sandler restated an “overweight” rating and set a $225.00 target price on shares of CME Group in a research report on Tuesday, August 20th. Four equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus target price of $209.73.

Insider Activity

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the sale, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

NASDAQ:CME opened at $220.50 on Friday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $223.80. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a fifty day simple moving average of $203.51 and a 200 day simple moving average of $207.59. The stock has a market capitalization of $79.39 billion, a PE ratio of 25.09, a P/E/G ratio of 6.51 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the business posted $2.30 earnings per share. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. On average, research analysts expect that CME Group Inc. will post 9.89 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.09%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.